Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 4/20 | 0.60 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.58 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | MME | P08473 | 4/20 | 0.55 |
| ▸ | CPA1 | P15085 | 1/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.51 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.49 |
| ▸ | CHRNG | P07510 | 1/20 | 0.49 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.49 |
| ▸ | CHRND | Q07001 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7110125 | 1.00 | ACE (0.60) | ACEFOLH1NAALAD2CA1CA2 | |
| SCHEMBL479125 | 1.00 | ACE (0.60) | ACEFOLH1NAALAD2CA1CA2 | |
| SCHEMBL3459805 | 1.00 | ACE (0.60) | ACEFOLH1NAALAD2CA1CA2 | |
| SCHEMBL7110134 | 1.00 | ACE (0.60) | ACEFOLH1NAALAD2CA1CA2 | |
| SCHEMBL28294791 | 0.98 | ACE (0.59) | ACEFOLH1NAALAD2CA1CA2 | |
| Water SCHEMBL22150379 | 0.98 | ACE (0.59) | ACEFOLH1NAALAD2CA1CA2 | |
| Water SCHEMBL7103036 | 0.98 | ACE (0.59) | ACEFOLH1NAALAD2CA1CA2 | |
| Water SCHEMBL27998556 | 0.98 | ACE (0.59) | ACEFOLH1NAALAD2CA1CA2 | |
| Water SCHEMBL9517059 | 0.98 | ACE (0.59) | ACEFOLH1NAALAD2CA1CA2 | |
| SCHEMBL28294788 | 0.98 | ACE (0.59) | ACEFOLH1NAALAD2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 848 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125735-A1 | METHOD OF DETECTING TARGET SUBSTANCE AND REAGENT FOR INSPECTION OF TARGET SUBSTANCE | CANON KK (JP) | 2026-05-07 | — | — | US | claimed |
| US-20260126443-A1 | METHOD OF DETECTING TARGET SUBSTANCE AND REAGENT FOR INSPECTION OF TARGET SUBSTANCE | CANON KK (JP) | 2026-05-07 | — | — | US | claimed |
| EP-4737585-A1 | METHOD OF DETECTING TARGET SUBSTANCE AND REAGENT FOR INSPECTION OF TARGET SUBSTANCE | Canon Kabushiki Kaisha (JP) | 2026-05-06 | — | — | EP | claimed |
| EP-4737586-A1 | METHOD OF DETECTING TARGET SUBSTANCE AND REAGENT FOR INSPECTION OF TARGET SUBSTANCE | Canon Kabushiki Kaisha (JP) | 2026-05-06 | — | — | EP | claimed |
| EP-4715061-A1 | PREPARATION METHOD FOR L-AMINO ACID LIGASE AND USE THEREOF IN DIPEPTIDE SYNTHESIS | Asymchem Life Science (Tianjin) Co., Ltd (CN) | 2026-03-25 | — | — | EP | claimed |
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | HAIKOU QIAOSHUI UNITED TECHNOLOGY CO. LTD. (CN) | 2026-03-12 | — | — | US | claimed |
| EP-4700130-A1 | PREPARATION METHOD FOR ALPHA-AMINO ACID ESTER ACYL TRANSFERASE AND USE THEREOF IN DIPEPTIDE SYNTHESIS | Asymchem Life Science (Tianjin) Co., Ltd (CN) | 2026-02-25 | — | — | EP | claimed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4659591-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | House Foods Group Inc. (JP) | 2025-12-10 | — | — | EP | claimed |
| EP-4659592-A1 | FLAVOR ENHANCING COMPOSITION, MANUFACTURING METHOD THEREFOR, AND METHOD FOR ENHANCING FLAVOR OF FOOD PRODUCT | House Foods Corporation (JP) | 2025-12-10 | — | — | EP | claimed |
| EP-0565863-A2 | Semi-synthetic glycosaminoglycans with heparin or heparan structure of alpha-L-iduronic-2-0-sulfate acid modified in position 2 | ALFA WASSERMANN S.p.A. (IT) | 1993-10-20 | — | — | EP | claimed |
| EP-0547065-A4 | MELANIN PRODUCTION BY TRANSFORMED MICROORGANISMS | — | 1993-09-15 | — | — | EP | claimed |
| EP-0547065-A1 | MELANIN PRODUCTION BY TRANSFORMED MICROORGANISMS | Biosource Technologies, Inc. (US) | 1993-06-23 | — | — | EP | claimed |
| WO-1992000373-A1 | MELANIN PRODUCTION BY TRANSFORMED MICROORGANISMS | BIOSOURCE GENETICS CORPORATION (CA) | 1992-01-09 | — | — | WO | claimed |
| US-4696914-A | Material for improving the fertility of mammals and process for its production | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1987-09-29 | — | — | US | claimed |
| US-4427762-A | DEVELOPMENT WITH ALKALINE DEVELOPER MIXTURE | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-01-24 | — | — | US | claimed |
| EP-0082015-A1 | Method of forming an image with a photographic cuprous halide material | KONICA CORPORATION (JP) | 1983-06-22 | — | — | EP | claimed |
| EP-0006792-B1 | IODINATED COMPOUND USABLE AS RADIO-IMMUNOLOGICAL TRACER AND ITS PROCESS OF PREPARATION | COMMISSARIAT A L'ENERGIE ATOMIQUE Etablissement de Caractère Scientifique Technique et Industriel (FR) | 1982-06-23 | — | — | EP | claimed |
| US-4331646-A | Iodine compound for use as a tracer in radioimmunology | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1982-05-25 | — | — | US | claimed |
| EP-0006792-A1 | Iodinated compound usable as radio-immunological tracer and its process of preparation | COMMISSARIAT A L'ENERGIE ATOMIQUE Etablissement de Caractère Scientifique Technique et Industriel (FR) | 1980-01-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260126443-A1 | METHOD OF DETECTING TARGET SUBSTANCE AND REAGENT FOR INSPECTION OF TARGET SUBSTANCE | TYR, UCHL1, TH | ACE 189/4885FOLH1 303/4885NAALAD2 304/4885 |
| US-20260125735-A1 | METHOD OF DETECTING TARGET SUBSTANCE AND REAGENT FOR INSPECTION OF TARGET SUBSTANCE | UCHL1, MAOA, ACHE | ACE 419/4885FOLH1 167/4885NAALAD2 319/4885 |
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | VIP, ANPEP, RNPEP | ACE 132/4885FOLH1 274/4885NAALAD2 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.